Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers.
BACKGROUND
Electronic cigarette (EC) use has grown exponentially over the past few years. The purpose of this survey was to assess the characteristics and experiences of a large sample of EC users and examine the differences between those who partially and completely substituted smoking with EC use.


METHODS
A questionnaire was prepared, translated into 10 different languages and uploaded in an online survey tool. EC users were asked to participate irrespective of their current smoking status. Participants were divided according to their smoking status at the time of participation in two subgroups: former smokers and current smokers.


RESULTS
In total, 19,414 participants were included in the analysis, with 88 of them (0.5%) reported not being smokers at the time of EC use initiation. Complete substitution of smoking was reported by 81.0% of participants (former smokers) while current smokers had reduced smoking consumption from 20 to 4 cigarettes per day. They were using ECs for a median of 10 months. They initiated EC use with a median of 18 mg/mL nicotine-concentration liquids; 21.5% used higher than 20 mg/mL. Only 3.5% of participants were using 0-nicotine liquids at the time of the survey. Former smokers were highly dependent (Fagerström Test for Cigarette Dependence = 7) and were heavier smokers (21 cigarettes per day when smoking) compared to current smokers. The most important reasons for initiating EC use for both subgroups was to reduce the harm associated with smoking and to reduce exposure of family members to second-hand smoking. Most considered ECs as less harmful than tobacco cigarettes, while 11.0% considered them absolutely harmless. Side effects were reported by more than half of the participants (59.8%), with the most common being sore/dry mouth and throat; side effects were mild and in most cases were subsequently resolved (partially or completely). Participants experienced significant benefits in physical status and improvements in pre-existing disease conditions (including respiratory disease such as asthma and chronic obstructive lung disease). Being former smoker was independently associated with positive effects in health and improvements in disease conditions.


CONCLUSIONS
The results of this worldwide survey of dedicated users indicate that ECs are mostly used to avoid the harm associated with smoking. They can be effective even in highly-dependent smokers and are used as long-term substitutes for smoking. High levels of nicotine are used at initiation; subsequently, users try to reduce nicotine consumption, with only a small minority using non-nicotine liquids. Side effects are minor and health benefits are substantial, especially for those who completely substitute smoking with EC use. Further population and interventional studies are warranted.
Onassis Cardiac Surgery Center, Sygrou 356, Kallithea 17674, Greece. kfarsalinos@gmail.com.
Konstantinos E
KE
Farsalinos
ABICH S.r.l, Biological and Chemical Toxicology Research Institute, Via 42 Martiri, 213, Verbania (VB) B-28924, Italy. giorgio.romagna@gmail.com.
Giorgio
G
Romagna
Onassis Cardiac Surgery Center, Sygrou 356, Kallithea 17674, Greece. dtsiapras@hotmail.com.
Dimitris
D
Tsiapras
Onassis Cardiac Surgery Center, Sygrou 356, Kallithea 17674, Greece. stkyrz@gmail.com.
Stamatis
S
Kyrzopoulos
Onassis Cardiac Surgery Center, Sygrou 356, Kallithea 17674, Greece. vvoudris@otenet.gr.
Vassilis
V
Voudris
D000328:Adult; D055615:Electrical Equipment and Supplies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010465:Perception; D012907:Smoking / Q000523:psychology; D016540:Smoking Cessation / Q000379:methods / Q000523:psychology / Q000706:statistics & numerical data; D011795:Surveys and Questionnaires; D062789:Tobacco Products / Q000009:adverse effects; D061485:Tobacco Use Cessation Devices / Q000706:statistics & numerical data*; D014029:Tobacco Use Disorder / Q000523:psychology